Data

A Phase III, randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer

Health Data Australia Contributor Records
Davidson, Andrew ; Thoracic Oncology Group Australasia (TOGA)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58106/914N-JZ74&rft.title=A Phase III, randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer&rft.identifier=http://doi.org/10.58106/914N-JZ74&rft.publisher=Thoracic Oncology Group Australasia (TOGA)&rft.description=Data for 372 adult patients with advanced non-small cell lung cancer. Treatment regime was standard chemotherapy with (n=185) or without (n=187) application of a nitroglycerin 25 mg patch. Study assessments were carried out at baseline before randomization, then every 3 weeks during chemotherapy, and every 4 weeks from completion of chemotherapy until disease progression. Dataset includes: Progression free survival, overall survival data, demographic data, diagnostic data, treatment data, quality of life data, objective tumour response. (RECIST 1.1), adverse events.&rft.creator=Davidson, Andrew &rft.creator=Thoracic Oncology Group Australasia (TOGA) &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12608000588392&rft_subject=Cancer&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

Data for 372 adult patients with advanced non-small cell lung cancer. Treatment regime was standard chemotherapy with (n=185) or without (n=187) application of a nitroglycerin 25 mg patch. Study assessments were carried out at baseline before randomization, then every 3 weeks during chemotherapy, and every 4 weeks from completion of chemotherapy until disease progression. Dataset includes: Progression free survival, overall survival data, demographic data, diagnostic data, treatment data, quality of life data, objective tumour response. (RECIST 1.1), adverse events.

Notes

HeSANDA 1.0.0

Issued: 2023

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Subjects
Cancer |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Cancer Council Western Australia

ROR : https://ror.org/0184qmt78

Cancer Council Queensland

ROR : https://ror.org/03g5d6c96

Cancer Council New South Wales

ROR : https://ror.org/05gsbkp40

National Health and Medical Research Council

ROR : https://ror.org/011kf5r70

Identifiers
Similar data you may be interested in: